Updates on Gene Expression Analyses in Anti-Cancer Drug Research
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 58
Special Issue Editors
2. Algarve Biomedical Centre Research Institute (ABC-RI), Campus de Gambelas, 8005-139 Faro, Portugal
Interests: cancer metabolism; obesity; drug repurposing; biomarkers; personalized medicine
Special Issues, Collections and Topics in MDPI journals
2. Escola Superior de Saúde, Universidade do Algarve (ESSUAlg), Campus de Gambelas, 8005-139 Faro, Portugal
Interests: biomarkers; cancer stemness; drug resistance; OMICS; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a Special Issue dedicated to the latest advancements in gene expression analyses within the context of anti-cancer drug research. As the understanding of cancer biology deepens, gene expression profiling has become increasingly pivotal in identifying novel therapeutic targets, predicting drug responses, and overcoming resistance mechanisms.
This Special Issue aims to showcase cutting-edge research that leverages gene expression analyses to enhance the development and efficacy of anti-cancer therapies. We invite researchers to submit original research articles and reviews that provide new insights into how gene expression data can be utilized to innovate and refine cancer treatment strategies. This issue will serve as a comprehensive resource for scientists and clinicians interested in integrating molecular biology and pharmacology to target and treat cancer more effectively.
Examples of anticipated, but non-exhaustive, submission topics are as follows:
- Gene expression profiling in drug-resistant cancers;
- Predictive biomarkers based on gene expression data;
- Impact of epigenetic modifications on gene expression and drug response;
- Gene expression signatures associated with immune checkpoint inhibitors;
- Novel computational approaches for analyzing gene expression in cancer;
- Gene expression changes in tumor microenvironments during therapy;
- Pharmacogenomics and personalized medicine in cancer treatment;
Dr. Ana Luísa De Sousa-Coelho
Dr. Mónica Fernandes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene expression profiling
- anti-cancer drug research
- drug resistance
- biomarkers
- pharmacogenomics
- single-cell RNA sequencing
- non-coding RNAs
- multi-omics data
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
